290 related articles for article (PubMed ID: 9486404)
1. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).
van den Berg RH; Siegert CE; Faber-Krol MC; Huizinga TW; van Es LA; Daha MR
Clin Exp Immunol; 1998 Feb; 111(2):359-64. PubMed ID: 9486404
[TBL] [Abstract][Full Text] [Related]
2. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
Starkebaum G; Arend WP
J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
[TBL] [Abstract][Full Text] [Related]
5. The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells.
van den Berg RH; Faber-Krol MC; Sim RB; Daha MR
J Immunol; 1998 Dec; 161(12):6924-30. PubMed ID: 9862726
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
Antes U; Heinz HP; Hartung K; Loos M
Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
Uwatoko S; Mannik M
J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.
Seelen MA; Trouw LA; van der Hoorn JW; Fallaux-van den Houten FC; Huizinga TW; Daha MR; Roos A
Clin Exp Immunol; 2003 Nov; 134(2):335-43. PubMed ID: 14616796
[TBL] [Abstract][Full Text] [Related]
9. Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization.
Eggleton P; Ward FJ; Johnson S; Khamashta MA; Hughes GR; Hajela VA; Michalak M; Corbett EF; Staines NA; Reid KB
Clin Exp Immunol; 2000 May; 120(2):384-91. PubMed ID: 10792392
[TBL] [Abstract][Full Text] [Related]
10. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
Kohro-Kawata J; Wener MH; Mannik M
J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
[TBL] [Abstract][Full Text] [Related]
11. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
[TBL] [Abstract][Full Text] [Related]
12. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
[TBL] [Abstract][Full Text] [Related]
13. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
[TBL] [Abstract][Full Text] [Related]
14. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
[TBL] [Abstract][Full Text] [Related]
15. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
16. Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin.
Sim RB; Moestrup SK; Stuart GR; Lynch NJ; Lu J; Schwaeble WJ; Malhotra R
Immunobiology; 1998 Aug; 199(2):208-24. PubMed ID: 9777407
[TBL] [Abstract][Full Text] [Related]
17. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
20. C1q inhibits autoantibody binding to calreticulin.
Racila DM; Sontheimer RD
Lupus; 1999; 8(4):300-4. PubMed ID: 10413209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
